Treatment-related considerations specific to semaglutide therapy include: Gastrointestinal adverse effects : Persistent nausea, vomiting, or diarrhea leading to inadequate fluid replacement creates a state of relative dehydration
Abbreviations GLP-1RAs: Glucagon-like peptide-1 receptor agonists T2DM: Type 2 diabetes mellitus DPP-4: Dipeptidyl peptidase IV GLP-1R: Glucagon-like peptide-1 receptor cAMP: Cyclic adenosine monophosphate PKA: Protein kinase A PI3K: Phosphatidylinositol 3-kinase Akt: Protein kinase B AD: Alzheimers diseases TRPV1: Transient receptor potential vanilloid 1 OA: Osteoarthritis KOA: Knee OA MIA: Monoiodoacetate IL-6: Interleukin 6 PGE2: Prostaglandin E2 NO: Nitric oxide ER: Endoplasmic reticulum IL-1: Interleukin-1 MMP-3: Matrix metalloproteinases-3 MMP-13: Matrix metalloproteinases-13 ROS: Reactive oxygen species BMI: Body mass index IBS: Irritable bowel syndrome ATP: Adenosine triphosphate SERT: Serotonin transporter TPH-1: Tryptophan hydroxylase-1 AC: Adenylate cyclase LPS: Lipopolysaccharide WAS: Water avoidance stress IBS-C: Constipation-predominant IBS SNL: Spinal nerve ligation SCI: Spinal cord injury CHOP: C/EBP homologous transcription factor protein GRP78: Glucose regulatory protein 78 PSNT: Partial sciatic nerve transection L
This session explores what sustainable maintenance looks like in the real world, including lower-dose, longer-duration treatment strategies, and asks what long-term health outcomes, from cardiovascular risk to metabolic function, become possible when treatment is truly sustained
As weight decreases, metabolism slows, and hunger hormones increase, making further weight loss progressively harder
7: 38 [DOI] [PubMed] [Google Scholar] 116.Yip RG, Boylan MO, Kieffer TJ, et al
